Translational Study of MSS, TP53 Mutation and Chromosome Instability Relationship in Endometrial Carcinoma
NCT06521684 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 110
Last updated 2024-07-26
Summary
The objective is to understand the relationship between TP53 mutation, MSS and chromosome instability in endometrial cancer and the effect on clinical prognosis.We will collect a small amount of tumor tissue samples. NGS panel detection and WGD/AS analysis were performed on the tissue. Paracancer tissue was used as a negative control and relevant information in medical records during the operation. Then we will collect clinical diagnosis and disease information through telephone follow-up after the completion of the operation.
Conditions
- Endometrial Neoplasms
- TP53 Gene Mutation
- Chromosomal Instability
- Microsatellite Stable Endometrial Carcinoma
Sponsors & Collaborators
-
Peking Union Medical College Hospital
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-09-01
- Primary Completion
- 2025-06-01
- Completion
- 2025-06-01
More Related Trials
-
Inherited Susceptible Genes Among Epithelial Ovarian Cancer
NCT03015376 ·Status: UNKNOWN
-
Chromosomal Instability in Ovarian Cancer
NCT05310357 ·Status: UNKNOWN
-
MRI and Metabolomics Biomarkers for Uterine Malignancy
NCT02528864 ·Status: COMPLETED
-
Exploring the Potential of ctDNA-MRD for Recurrence Surveillance and Prognostic Evaluation in High-risk Endometrial Cancer
NCT06341855 ·Status: RECRUITING ·Phase: NA
-
Prospective Multi-omics Observational Study of Gynecological Rare Pathological Tumors
NCT05985941 ·Status: NOT_YET_RECRUITING
-
Studies of the Tumour Suppressor Gene PTEN - Endometrial Cancer
NCT02724501 ·Status: COMPLETED
-
The Association of G9a Protein and Outcome of Patients With Endometrial Cancer
NCT01271764 ·Status: COMPLETED ·Phase: NA
-
Molecular and ctDNA Characterization of High-Risk Endometrial Cancer
NCT07062016 ·Status: RECRUITING
-
Analysis of miRNA Expression in Endometrial Cancer
NCT04845425 ·Status: UNKNOWN
-
The Impact of Epigenetic MMRd in Endometrial carcinomas-a Real World Study
NCT05334303 ·Status: UNKNOWN
-
Identifying MSI Status From ctDNA in Chinese Patients With Refractory Advanced Solid Tumors
NCT03596593 ·Status: UNKNOWN ·Phase: NA
-
The Role of Hypoxia as a Selective Pressure for TP53 Mutations
NCT03466034 ·Status: TERMINATED
-
Molecular Mechanism Study of Uterine Sarcoma
NCT05881967 ·Status: RECRUITING
-
Reliability and Interest of Circulating Tumor DNA in Endometrial Cancers.
NCT04456972 ·Status: COMPLETED ·Phase: NA
-
Role of Senescence in the Development of Endometrial Cancer
NCT03338985 ·Status: UNKNOWN ·Phase: NA
-
Pre-Clinical Models in Gynecological Tumors A Tissue Repository
NCT00250783 ·Status: COMPLETED
-
The Role of POLE Mutation in High Risk Endometrial Cancer.
NCT07114653 ·Status: RECRUITING
-
Mutational Oncology in Clinical Practice
NCT06020625 ·Status: RECRUITING ·Phase: NA
-
Evaluation of MCM5 in Postmenopausal Bleeding Patients
NCT05287048 ·Status: UNKNOWN
-
Endometrial Cancer and Array CGH
NCT02833896 ·Status: COMPLETED
-
Homologous Recombination Deficiency Status in Epithelial Ovarian Cancer
NCT04190667 ·Status: UNKNOWN
-
Prediction of Postoperative Treatment Efficacy and Recurrence Risk of High-risk GIST Based on Liquid Biopsy MRD
NCT05408897 ·Status: RECRUITING
-
A Study to Analyze Data on Metastatic Ovarian Cancer Using Multi-omics
NCT05251883 ·Status: RECRUITING
-
Lynch Syndrome Can be Diagnosed Just From Somatic Mismatch Repair Mutation
NCT04516083 ·Status: UNKNOWN
-
Registry Study in MSI/dMMR Solid Tumors
NCT06004713 ·Status: RECRUITING